ReviewDrugs in context2023

Individuals at risk for severe COVID-19 in whom ritonavir-containing therapies are contraindicated or may lead to interactions with concomitant medications: a retrospective analysis of German health insurance claims data.

Christoph Lübbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.